These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15610560)

  • 1. From bench to clinic and back: Perspective on the 1st IQPC Translational Research conference.
    Hörig H; Pullman W
    J Transl Med; 2004 Dec; 2(1):44. PubMed ID: 15610560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational research in the pharmaceutical industry: from bench to bedside.
    O'Connell D; Roblin D
    Drug Discov Today; 2006 Sep; 11(17-18):833-8. PubMed ID: 16935752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing strategies to enhance health services research capacity in a predominantly rural Canadian health authority.
    Miller J; Bryant Maclean L; Coward P; Broemeling AM
    Rural Remote Health; 2009; 9(4):1266. PubMed ID: 20028187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing candidate selection--a vision in business limited conference. 1-2 December 1998, Basel, Switzerland.
    Audus KL
    IDrugs; 1999 Feb; 2(2):91-3. PubMed ID: 16160941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Translational research: an interpretation].
    Guimarães R
    Cien Saude Colet; 2013 Jun; 18(6):1731-44. PubMed ID: 23752539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Modern Drug Discovery.
    Eder J; Herrling PL
    Handb Exp Pharmacol; 2016; 232():3-22. PubMed ID: 26330257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).
    Chen X; Andersson R; Cho WC; Christiani D; Coico R; Drazen J; Ege M; Fehniger T; Gao H; Jin K; Liebman MN; Lopez E; Marraro G; Marko-Varga G; Marincola FM; Popescu LM; Spada C; Shahzad A; Wang E; Wang W; Wang X; Wang YX; Xia J; Qu J
    Clin Transl Med; 2012 Aug; 1(1):15. PubMed ID: 23369397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturing road map for tissue engineering and regenerative medicine technologies.
    Hunsberger J; Harrysson O; Shirwaiker R; Starly B; Wysk R; Cohen P; Allickson J; Yoo J; Atala A
    Stem Cells Transl Med; 2015 Feb; 4(2):130-5. PubMed ID: 25575525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of translational epidemiology: from scientific discovery to population health impact.
    Khoury MJ; Gwinn M; Ioannidis JP
    Am J Epidemiol; 2010 Sep; 172(5):517-24. PubMed ID: 20688899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?
    Eichler HG; Kong SX; Grégoire JP
    Eur J Health Econ; 2006 Jun; 7(2):129-35. PubMed ID: 16485122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging of pain: advances and future prospects.
    Stephenson DT; Arneric SP
    J Pain; 2008 Jul; 9(7):567-79. PubMed ID: 18455479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.